AGP Executive Report
Last update: 12 hours agoHemp & CBD Policy: The Trump administration says it’s ready to work with Congress to update how “final hemp-derived cannabinoid products” are defined, aiming to preserve access to full-spectrum CBD while avoiding a return to stricter federal limits. Rescheduling Impact: A new federal downgrade for medical cannabis (Schedule I to Schedule III) is expected to open the door to some federal tax benefits and new research, though recreational cannabis remains federally restricted. State Regulation Watch: Pennsylvania lawmakers rejected a bill that would have regulated marijuana and restricted hemp THC products, while Texas’ smokable-hemp rule is back in effect but enforcement is unclear. Local Cannabis Access: California’s Amador County dispensary push moves forward with a community listening session, and Hamilton, Ohio is holding a public hearing that could end its long dispensary ban via zoning changes. Municipal Enforcement & Public Health: Manitou Springs’ budget survey shows residents oppose cuts to public safety as recreational marijuana competition squeezes local revenue. Other Drug Policy: Massachusetts towns consider kratom sale bans amid concerns about more potent adulterated products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
